<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03064620</url>
  </required_header>
  <id_info>
    <org_study_id>8024-10</org_study_id>
    <nct_id>NCT03064620</nct_id>
  </id_info>
  <brief_title>PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study</brief_title>
  <acronym>PICRcarriage</acronym>
  <official_title>PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Palestinian-Israeli Collaborative Research (PICR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Agency for International Development (USAID)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Israeli National Institute for Health Policy Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maccabi Healthcare Services Research Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: PCV effects on S. pneumoniae and S. aureus carriage in a population based study.
      The major specific aims:

        1. To compare different PCV vaccination policies, by cross-sectional repeated surveillance
           of closely related populations living in regions with different vaccination policies.

        2. To compare the epidemiology, predictors and outcomes of antibiotic resistant S. aureus
           and S. pneumoniae in different regions of the PICR.

      Study design: Annual / Biannual cross-sectional surveillance of nasal S. aureus carriage and
      nasopharyngeal S. pneumoniae carriage in children and one of their parents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design: Annual / Biannual cross-sectional surveillance of nasal S. aureus carriage and
      nasopharyngeal S. pneumoniae carriage in children and one of their parents.

      PICR districts: 1. Palestinian Authority (PA) - particularly: Bethlehem, Ramallah and
      Nabulus. 2. East Jerusalem (EJ) 3. Central Israel (IL) - particularly: Rishon Lezion, Bat
      Yam, Holon 4. Gaza strip (GZ) - 12 regions including cities/villages in central/northern
      Gaza.

      Study population:

      Child (age 0-5y) &amp; Parent who attend clinics (for any reason).

      Exclusion criteria:

      Parent does not agree to sign informed consent Child or sibling (brother/sister) have already
      participated.

      Both healthy and ill children are screened. No specific exclusion other than the above.

      Only one child per family (younger child, if more than one available) and one parent (mother,
      if both are available).

      Sample size per year:

      IL: Central Israel (Hashfela District): 400 pairs of child+parent/surveillance EJ: East
      Jerusalem: 400 pairs of child+parent/surveillance PA: West Bank cities (Ramallah, Bethlehem &amp;
      Nabulus): 600 pairs of child+parent/surveillance GZ: Gaza strip: 300 pairs of
      child+parent/surveillance

      Study Period:

      May-August annually 2009 - 2011 - (Part a). May-August biannually 2014-2016-2018-2020 Current
      study (Part b).

      Screening Procedure:

        1. Parent signs informed consent

        2. Put Barcode stickers on informed consent, questionnaire, swabs and daily list

        3. Fill questionnaire with parent.

        4. Fill physician questionnaire

        5. Nasal &amp; nasopharyngeal swab of child and parent.

        6. Fill daily working table.

        7. Write the number of refusals (parents who refused) on daily table.

        8. Fill questionnaire FULLY (unmarked questions will not be analyzed) - put x on each
           question - whether YES or NO.

      Swabbing:

        1. First swab the child and then follow with the parent.

        2. First perform nasal swab (for S. aureus) using cotton-tip swab placed into Amies
           transport Media (Blue) and follow with nasopharyngeal swab ( for S. pneumoniae) using
           rayon-tipped aluminum shaft swab placed in Amies transport Media (Orange).

        3. Slightly wet the nasal swab with sterile saline. Swab both anterior nares.

        4. Nasopharyngeal swab of only through one nostril - gently, quickly and deep to
           nasopharynx - until you touch the nasopharyngeal wall.

      Swab transfer to lab:

      If swabs are stored overnight before transfer - keep in 40C (fridge). Within 24h swabs must
      reach the central laboratory (Dr. Regev-Yochay's Lab at Sheba Medical Center).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>S. pneumoniae carriage</measure>
    <time_frame>1 Day</time_frame>
    <description>S. pneumoniae carriage of children and parents by the different groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Carriage of Vaccine-type S. pneumoniae</measure>
    <time_frame>1 Day</time_frame>
    <description>Carriage of Vaccine-type S. pneumoniae in children and parents by the different groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carriage of antibiotic resistant S. pneumonia</measure>
    <time_frame>1 Day</time_frame>
    <description>Carriage of antibiotic resistant S. pneumonia in children and parents by the different groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carriage of piliated S. pneumonia</measure>
    <time_frame>1 Day</time_frame>
    <description>Carriage of piliated S. pneumonia in children and parents by the different groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carriage of MRSA</measure>
    <time_frame>1 Day</time_frame>
    <description>Carriage of MRSA in children and parents by the different groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>S. aureus carriage</measure>
    <time_frame>1 Day</time_frame>
    <description>S. aureus carriage of children and parents by the different groups</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">12800</enrollment>
  <condition>Streptococcus Pneumoniae</condition>
  <arm_group>
    <arm_group_label>Israel PCV13</arm_group_label>
    <description>Children and their parents living in central Israel and visiting primary pediatric clinics of Hashfela District, Macabbi Healthcare Services HMO, for any reason during the surveillance period each year.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>East Jerusalem PCV13</arm_group_label>
    <description>Children and their parents living in East Jerusalem and visiting primary pediatric clinics of Jerusalem District, Macabbi Healthcare Services HMO, for any reason during the surveillance period each year.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Palestine PCV7 PCV10</arm_group_label>
    <description>Children and their parents living in major cities of the Palestinian Authority and visiting private primary pediatric clinics, for any reason during the surveillance period each year.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PCV</intervention_name>
    <description>PCV7 was introduced in Israel (IL and EJ) in July 2009 PCV13 replaced PCV7 in IL and EJ on Oct 2010 PCV10 was introduced in PA in 2011</description>
    <arm_group_label>Israel PCV13</arm_group_label>
    <arm_group_label>East Jerusalem PCV13</arm_group_label>
    <arm_group_label>Palestine PCV7 PCV10</arm_group_label>
    <other_name>PCV7</other_name>
    <other_name>PCV10</other_name>
    <other_name>PCV13</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      S. aureus and S. pneumoniae
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Child (age 0-5y) &amp; Parent who attend pediatric clinics (for any reason), in the
        participating clinics during the surveillance periods.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any child younger than 5 years, visiting the participating clinics during the
             surveillance period

        Exclusion Criteria:

          -  Older than 5 years

          -  Previously participated in the study.

          -  Sibling has participated in the study.

          -  Parent does not agree to sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dror Harats, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>IRB Committee Sheba Medical Center Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gili Regev-Yochay, MD</last_name>
    <phone>0526666197</phone>
    <email>gili.regev.y@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ziad Abdeen, PhD</last_name>
    <email>zabdeen13@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <zip>5265601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gili Regev-Yochay</last_name>
      <phone>0526666197</phone>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Daana M, Rahav G, Hamdan A, Thalji A, Jaar F, Abdeen Z, Jaber H, Goral A, Huppert A, Raz M, Regev-Yochay G; PICR study group. Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR). Vaccine. 2015 Feb 18;33(8):1021-6. doi: 10.1016/j.vaccine.2015.01.003. Epub 2015 Jan 12.</citation>
    <PMID>25593104</PMID>
  </reference>
  <reference>
    <citation>Southern J, Roizin H, Daana M, Rubin C, Hasleton S, Cohen A, Goral A, Rahav G, Raz M, Regev-Yochay G; PICR group. Varied utilisation of health provision by Arab and Jewish residents in Israel. Int J Equity Health. 2015 Aug 7;14:63. doi: 10.1186/s12939-015-0193-8.</citation>
    <PMID>26245327</PMID>
  </reference>
  <reference>
    <citation>Regev-Yochay G, Abullaish I, Malley R, Shainberg B, Varon M, Roytman Y, Ziv A, Goral A, Elhamdany A, Rahav G, Raz M; Palestinian-Israeli Collaborative Research Study Group. Streptococcus pneumoniae carriage in the Gaza strip. PLoS One. 2012;7(4):e35061. doi: 10.1371/journal.pone.0035061. Epub 2012 Apr 23.</citation>
    <PMID>22539955</PMID>
  </reference>
  <reference>
    <citation>Biber A, Abuelaish I, Rahav G, Raz M, Cohen L, Valinsky L, Taran D, Goral A, Elhamdany A, Regev-Yochay G; PICR Study Group. A typical hospital-acquired methicillin-resistant Staphylococcus aureus clone is widespread in the community in the Gaza strip. PLoS One. 2012;7(8):e42864. Epub 2012 Aug 16.</citation>
    <PMID>22916171</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2016</study_first_submitted>
  <study_first_submitted_qc>February 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2017</study_first_posted>
  <last_update_submitted>February 22, 2017</last_update_submitted>
  <last_update_submitted_qc>February 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Gili Regev-Yochay MD</investigator_full_name>
    <investigator_title>Head of Infect Dis Epi Section, Gertner</investigator_title>
  </responsible_party>
  <keyword>PCV effects</keyword>
  <keyword>S. pneumoniae carriage</keyword>
  <keyword>S. aureus carriage</keyword>
  <keyword>Indirect vaccination effects</keyword>
  <keyword>Palestinian-Israeli Collaborative Research (PICR)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

